Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Inge van der Sluis

Pediatric oncologist
Inge van der Sluis
Inge van der Sluis
--
  • Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL

    • feb. 2024
    • Inge M, van der Sluis, et al
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Improved Outcome for ALL by Prolonging Therapy for IKZF1 Deletion and Decreasing Therapy for Other Risk Groups

    • sep. 2023
    • Rob, Pieters, et al
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Randomized controlled trial on the effect of 1-hour infusion of vincristine versus push injection on neuropathy in children with cancer (final analysis)

    • jan. 2023
    • Aniek, Uittenboogaard, et al
    • Cancer Medicine
  • Health-related quality of life and its determinants during and after treatment for paediatric acute lymphoblastic leukaemia: a national, prospective, longitudinal study in the Netherlands

    • jan. 2023
    • Emily R., Schwartz, et al
    • BMJ open
  • Higher incidence of delayed methotrexate clearance in pediatric acute lymphoblastic leukemia patients treated with imatinib

    • jan. 2023
    • Inge, van der Sluis, et al
    • EJC Pediatric Oncology
View all publications